Vimarsana
Biggest News Aggregation in the World

Page 2 - Diagnostic Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostic Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostic Services Today - Breaking & Trending Today

Health ministry calls for functionalization of local accreditation body - Vimarsana News

Health ministry calls for functionalization of local accreditation body

Mr Ogwok was speaking on Friday at the UGANAS offices in Nakawa where the Joint Clinical Research Centre was donating a double cabin pickup to support the operations of the UGANAS.

Q2 2024 EPS Estimates for Star Equity Holdings, Inc. (NASDAQ:STRR) Reduced by Analyst - Vimarsana News

Q2 2024 EPS Estimates for Star Equity Holdings, Inc. (NASDAQ:STRR) Reduced by Analyst

Star Equity Holdings, Inc. (NASDAQ:STRR – Free Report) – Equities research analysts at Litchfield Hills Research dropped their Q2 2024 earnings per share estimates for Star Equity in a research note issued on Monday, March 25th. Litchfield Hills Research analyst T. O’neill now forecasts that the company will post earnings of ($0.07) per share for […]

Source: wkrb13.com
Global Medical Imaging Services Market Report 2024-2029: Role of X-rays, CT Scans, and MRI in Accurate Diagnosis Elevates Demand - Vimarsana News

Global Medical Imaging Services Market Report 2024-2029: Role of X-rays, CT Scans, and MRI in Accurate Diagnosis Elevates Demand

/PRNewswire/ -- The "Global Medical Imaging Services Market (2024 Edition): Analysis By Modality (X-ray, MRI, CT scan, Others), Technology (2D, 3D/4D), By End...

Global Medical Imaging Services Market Report 2024: Growing - Vimarsana News

Global Medical Imaging Services Market Report 2024: Growing

Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The

ProPhase Labs (NASDAQ:PRPH) Receives Buy Rating from HC Wainwright - Vimarsana News

ProPhase Labs (NASDAQ:PRPH) Receives Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of ProPhase Labs (NASDAQ:PRPH – Free Report) in a research note released on Wednesday morning, Benzinga reports. HC Wainwright currently has a $11.00 target price on the stock. ProPhase Labs Price Performance PRPH stock opened at $4.96 on Wednesday. The company has a fifty day moving average […]